Skip to content
Screener

Bio-Techne TECH Protein Sciences — Selling General And Administrative Expense

Other segment segments

Diagnostics And Spatial Biology
$27.62M-17.4%

Similar metrics at other companies

Ashland logo
ASHLife Sciences — Selling General And Administrative Expense
$20M+11.1%
Ecolab logo
ECLGlobal Life Sciences — Selling General And Administrative Expense
$55.2M+8.0%
RCM Technologies logo
RCMTLife Sciences Data Solutions — Selling General And Administrative Expense
$1.2M-16.0%
Phibro Animal Health logo
PAHCMineral Nutrition — Selling General And Administrative Expense
$1.99M+0.7%
Armstrong World Industries logo
AWIMineral Fiber — Selling General And Administrative Expense
$48.7M+10.7%
Flexible Solutions International logo
FSISelling General And Administrative Expense
$762.36K+0.8%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.22B+43.5%
Enterprise value$11.3B+39.5%
P/E74.9×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemProtein SciencesDiagnostics and Spatial BiologyTotal
Consolidated net sales$311,415
Segment operating income
Cost of sales53,79438,649
Selling, general and administrative57,90927,616
Research and development14,4529,002
Segment operating income$$99,999$10,319110,318
Unallocated amounts
Amortization of intangibles(15,382)

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's protein sciences — selling general and administrative expense?
Bio-Techne (TECH) reported protein sciences — selling general and administrative expense of $57.91M in Q1 2026.
How has Bio-Techne's protein sciences — selling general and administrative expense changed year-over-year?
Bio-Techne's protein sciences — selling general and administrative expense increased by 3.8% year-over-year, from $55.8M to $57.91M.
What is the long-term trend for Bio-Techne's protein sciences — selling general and administrative expense?
Over 2 years (2023 to 2025), Bio-Techne's protein sciences — selling general and administrative expense has grown at a 5.8% compound annual growth rate (CAGR), from $204.48M to $229.06M.
What does protein sciences — selling general and administrative expense mean?
This represents the operating expenses incurred to support the sales, marketing, and general corporate functions of the Protein Sciences segment. It includes salaries for non-manufacturing staff, marketing campaigns, legal fees, and administrative overhead. These costs are essential for maintaining market presence and supporting the segment's infrastructure.

Ask your AI about Bio-Techne's protein sciences — selling general and administrative expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude